

Pathway Genomics is a CAP accredited global clinical lab offering genetic tests for cancer risk, drug responses, and other conditions. Among its major competitors, Pathway Genomics is ranked in 9th place for NPS while Medtronic is 1st, and Ancestry is 2nd.Their current valuation is $150.00M